000 03036cam  2200481zi 4500
0019.879212
003CaOODSP
00520221107165441
006m     o  d f      
007cr |||||||||||
008190912t20202019onc    |o    f00| 0 eng d
020 |a9780660326016
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-339/2020E-PDF
24500|aVaccine acceptability factors for the general public and health care professionals in Canada.
264 1|a[Ottawa] : |bHealth Canada = Santé Canada,|c[2020]
264 4|c©2019
300 |a1 online resource (96 pages) + |e1 executive summary (vii pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Facteurs d'acceptabilité des vaccins pour le grand public et les professionnels de la santé au Canada.
500 |aCover title.
500 |aIssued also in HTML format.
500 |a"Prepared for Health Canada/Public Health Agency of Canada."
500 |a"Supplier Name: Environics Research."
500 |a"Contract Number: 6D034-184641/001/CY."
500 |a"Registration Number: POR 138-18."
520 |a"The research provides current data on the opinions and attitudes of the Canadian population regarding vaccination in general, and for specific vaccines and vaccine-preventable diseases. The results of this research will inform the development of evidence-based vaccine recommendations that include a consideration of acceptability of vaccines and vaccine programs. Results will be used to support the expansion of the mandate of the National Advisory Committee on Immunization (NACI) to include the systematic consideration of programmatic factors (economics, ethics, equity, feasibility, acceptability) in addition to burden of disease and vaccine characteristics"--page i.
650 0|aVaccination|zCanada|xPublic opinion.
650 0|aVaccines|zCanada|xPublic opinion.
650 0|aCommunicable diseases|zCanada|xPublic opinion.
650 0|aMedical personnel|zCanada|xAttitudes.
650 0|aPublic opinion|zCanada.
7101 |aCanada. |bHealth Canada.
7102 |aEnvironics Research Group.
77508|tFacteurs d'acceptabilité des vaccins pour le grand public et les professionnels de la santé au Canada.|w(CaOODSP)9.879213
85640|qPDF|s1,015 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H14-339-2020-eng.pdf|zFinal report
85640|qPDF|s266 KB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H14-339-2020-1-eng.pdf|zExecutive summary
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/138-18-e/environics_PHAC_vaccine_report_final-eng.html|zFinal report
8564 |qHTML|sN/A|uhttps://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2020/138-18-e/summary/environics_PHAC_vaccine_report_executive_summary_final-eng.html|zExecutive summary